Does Semaglutide Affect Your Sense of Smell?

What semaglutide's official side-effect data says about smell

The starting point is the published evidence. The STEP 1 trial (68 weeks, semaglutide 2.4mg versus placebo in adults with obesity) is the largest controlled dataset behind Wegovy's licence, and its safety reporting does not list smell disturbance as a recognised or common adverse event. The NHS medicines page for semaglutide sets out the confirmed side-effect profile: nausea, vomiting, diarrhoea, constipation, stomach discomfort and fatigue top the list. Direct olfactory dysfunction does not appear there.

That absence matters, but it is not the whole story. Pharmacovigilance databases, including the MHRA's Yellow Card system, collect self-reported experiences that can flag signals not captured in controlled trials. Smell-related reports exist in these databases for GLP-1 medicines generally, though at low frequency and without an established causal mechanism. The Yellow Card scheme exists precisely for this reason: if you notice something unusual on treatment, reporting it contributes to the ongoing safety picture for everyone.

The honest summary is that direct smell loss as a pharmacological action of semaglutide is not established by the current licensed evidence. But changes in how you experience smell (and particularly how food smells) are a genuinely reported phenomenon, and the biology behind it is worth examining.

Why food can smell different when nausea and appetite change

Smell and appetite are tightly coupled systems. Semaglutide acts on GLP-1 receptors in the brain regions that govern satiety and food reward, slowing gastric emptying and reducing the drive to eat. When nausea is present (common in the first weeks of treatment or after a dose step) the brain actively suppresses appetite-related sensory signals, and that can include the pleasurable or neutral perception of food aromas.

This is not the same as losing your sense of smell clinically. Most people describe food smelling less appealing, or certain smells triggering nausea, rather than losing the ability to detect odours at all. Some describe previously neutral smells becoming aversive. These experiences tend to track the GI symptom pattern: most pronounced early in treatment or after dose increases, then settling as the body adjusts. Our semaglutide overview covers the full side-effect context if you want the wider picture.

If you are finding that smells are making nausea worse, smaller meals, avoiding strong cooking odours while food is hot, and eating slowly are practical adjustments — though your prescriber is the right person to tailor advice to your situation. The Wegovy treatment page has more on managing early side effects.

When a smell change is worth flagging to a clinician

The distinction that matters clinically is between altered smell perception linked to nausea (manageable and typically transient) and persistent, unexplained anosmia (complete smell loss) that does not track with GI symptoms. If you notice that your sense of smell is significantly impaired and nausea is not the obvious driver, or if the change persists well beyond the adjustment phase, that is worth raising with your prescriber rather than waiting to see if it resolves.

Similarly, if you are on semaglutide and experience symptoms that feel neurological rather than gastrointestinal, the prescriber who reviewed your treatment is the right first contact. It is also worth knowing that if you would like to understand more about specific sensory changes people report, our pages on smell sensitivity on semaglutide and what semaglutide itself smells like address those distinct questions separately.

Some readers come to this topic after noticing changes to other sensory experiences on treatment. There is, for instance, a separate question about whether semaglutide affects urine odour, a question covered in detail on our page about whether Wegovy can change the smell of urine. Sleep-related side effects attract similar curiosity, and if that is also on your mind, this page on Wegovy and nightmares covers what the evidence says there.

The practical message: altered smell perception on semaglutide is real enough to take seriously but, in the majority of cases, reflects appetite and nausea changes rather than direct nerve involvement. Track it, report it via Yellow Card if it is significant, and involve your prescriber if it is persistent or severe.

Thinking about starting Wegovy, or already on it and have questions?

If you are weighing up whether Wegovy is the right option for you, reading about its side-effect profile (including less-discussed effects like the ones on this page) is a sensible part of the process. It is also exactly the kind of thing to raise in a clinical consultation. You might find it reassuring to know that at a service like ours, a GPhC-registered prescriber reads your consultation personally before any prescription is issued. There is no algorithm making that call.

Our weight-loss treatment overview sets out the options available and what clinical assessment covers. For a fuller look at costs and what an honest price comparison involves, the Wegovy cost and access guide is worth a read. We know it can feel daunting to ask about something as specific as how a medicine might change your senses, our prescribers hear questions like this regularly, and no question is too niche to raise.